FP32
2128
Dr.Soumya Basanth
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 2128 | Dr.Soumya Basanth | soumyabasanth@yahoo.com | 9845277198 |
Cornea, Ocular Surface and External Eye Diseases
To compare the outcomes of treatment with IRPL versus IRPL + Lifitegrast
Purpose: To compare the efficacy of Intense Regulated Pulsed Light (IRPL) alone versus IRPL combined with Lifitegrast 5% in patients with meibomian gland dysfunction (MGD)-associated dry eye disease. Methods: In this comparative study, patients with MGD-related dry eye received either IRPL alone or IRPL plus topical Lifitegrast 5%. Outcomes included Ocular Surface Disease Index (OSDI), tear film break-up time (TBUT), corneal fluorescein staining, Schirmer’s test, and meibomian gland function, assessed at baseline and follow-up. Results: Both groups showed significant clinical improvement. However, the IRPL plus Lifitegrast group demonstrated greater improvement in OSDI, TBUT, corneal staining, and meibomian gland function than the IRPL-alone group. Conclusion: The addition of Lifitegrast to IRPL provides superior improvement in signs and symptoms of MGD-associated dry eye compared with IRPL alone, supporting combined therapy as an effective treatment strategy.
No Co-Author Selected